Literature DB >> 28196555

DOHaD at the intersection of maternal immune activation and maternal metabolic stress: a scoping review.

J A Goldstein1, S A Norris2, D M Aronoff1.   

Abstract

The prenatal environment is now recognized as a key driver of non-communicable disease risk later in life. Within the developmental origins of health and disease (DOHaD) paradigm, studies are increasingly identifying links between maternal morbidity during pregnancy and disease later in life for offspring. Nutrient restriction, metabolic disorders during gestation, such as diabetes or obesity, and maternal immune activation provoked by infection have been linked to adverse health outcomes for offspring later in life. These factors frequently co-occur, but the potential for compounding effects of multiple morbidities on DOHaD-related outcomes has not received adequate attention. This is of particular importance in low- or middle-income countries (LMICs), which have ongoing high rates of infectious diseases and are now experiencing transitions from undernutrition to excess adiposity. The purpose of this scoping review is to summarize studies examining the effect and interaction of co-occurring metabolic or nutritional stressors and infectious diseases during gestation on DOHaD-related health outcomes. We identified nine studies in humans - four performed in the United States and five in LMICs. The most common outcome, also in seven of nine studies, was premature birth or low birth weight. We identified nine animal studies, six in mice, two in rats and one in sheep. The interaction between metabolic/nutritional exposures and infectious exposures had varying effects including synergism, inhibition and independent actions. No human studies were specifically designed to assess the interaction of metabolic/nutritional exposures and infectious diseases. Future studies of neonatal outcomes should measure these exposures and explicitly examine their concerted effect.

Entities:  

Keywords:  child growth and health; obesity; outcome/system; pregnancy

Mesh:

Year:  2017        PMID: 28196555     DOI: 10.1017/S2040174417000010

Source DB:  PubMed          Journal:  J Dev Orig Health Dis        ISSN: 2040-1744            Impact factor:   2.401


  4 in total

Review 1.  Maternal Immune Activation Hypotheses for Human Neurodevelopment: Some Outstanding Questions.

Authors:  Thomas G O'Connor; Allison A Ciesla
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-10-21

2.  Fetal exposure to maternal inflammation interrupts murine intestinal development and increases susceptibility to neonatal intestinal injury.

Authors:  Timothy G Elgin; Erin M Fricke; Huiyu Gong; Jeffrey Reese; David A Mills; Karen M Kalantera; Mark A Underwood; Steven J McElroy
Journal:  Dis Model Mech       Date:  2019-10-21       Impact factor: 5.758

Review 3.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

4.  Maternal Peripartum Serum DDT/E and Urinary Pyrethroid Metabolite Concentrations and Child Infections at 2 Years in the VHEMBE Birth Cohort.

Authors:  Jonathan Huang; Brenda Eskenazi; Riana Bornman; Stephen Rauch; Jonathan Chevrier
Journal:  Environ Health Perspect       Date:  2018-06-14       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.